Wednesday, 18 May, 2022

Topic: GlaxoSmithKline

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

GlaxoSmithKline, CureVac team up to develop vaccines to tackle Covid variants

The immunisations may be used to protect people who haven’t been inoculated or as booster shots if immunity from other vaccines wanes.

Sanofi and Glaxo start human trials for Covid-19 vaccine

The drugmakers, who have 11 trial sites across the US, aim to have results by December, allowing for the final phase of trials to begin.

Sanofi expects to get approval for its coronavirus vaccine in first half of 2021

Paris-based pharma giant Sanofi’s program with Britain's Glaxo is one of dozens sprinting to deliver a vaccine to help end the pandemic.

Unilever needs luck to gain energy from Horlicks deal in India

Horlicks is facing a challenge, even in India. The drink is losing its star status as the ‘healthy’ morning and after-school drink.

Glaxo to consider selling its stake in Indian consumer unit worth $3.1 bn

Revenue at GlaxoSmithKline's consumer unit in India has decreased in the last two years.  Its bestselling malted milk drink brand Horlicks will also be sold.

On Camera


File photo of Assi Ghat, Varanasi | Representative Image | Neera Majumdar | ThePrint

Forget Gyanvapi for a moment, Varanasi needs justice for a recent carnage: 2006 IM bombings

The real victim of the Varanasi bombing investigation has been the idea of justice. It's more lethal than any bombs the Indian Mujahideen planted.
File image of Tata Group's headquarters in Mumbai | Photo: Dhiraj Singh | Bloomberg

Tata in acquisition talks with as many as 5 brands, to bolster position in consumer goods sector

The conglomerate will likely face stiff competition in the sector from existing global giants such as Unilever, as well as Indian tycoon Mukesh Ambani’s Reliance Industries.


Satellite image of the development on the site | Twitter | @detresfa_

China building ‘bigger, broader’ 2nd bridge at Pangong Tso that can carry armoured columns

China's People's Liberation Army aims for multiple routes to counter any possible operations by the Indian forces on the southern banks of the Pangong Tso in the future.

How Congress is like the Ambassador & why Indian politics needs a brand new set of wheels

Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.